Synonyms: compound 19f [PMID: 7830278] | OPC-6535 | OPC6535
Compound class:
Synthetic organic
Comment: Tetomilast is a PDE4 inhibitor. Inhibition of PDE4 blocks the oxidative burst in human neutrophils, which is a major mediator of tissue injury in inflammatory diseases. Tetomilast (OPC-6535) was originally identified as an inhibitor of superoxide production by human neutrophils [1]. The clinical potential of PDE4 inhibition in inflammatory bowel disease was reviewed by Salari and Abdollahiin 2012 [2].
|
|
References |
1. Chihiro M, Nagamoto H, Takemura I, Kitano K, Komatsu H, Sekiguchi K, Tabusa F, Mori T, Tominaga M, Yabuuchi Y. (1995)
Novel thiazole derivatives as inhibitors of superoxide production by human neutrophils: synthesis and structure-activity relationships. J Med Chem, 38 (2): 353-8. [PMID:7830278] |
2. Salari P, Abdollahi M. (2012)
Phosphodiesterase inhibitors in inflammatory bowel disease. Expert Opin Investig Drugs, 21 (3): 261-4. [PMID:22303952] |
3. Schreiber S, Keshavarzian A, Isaacs KL, Schollenberger J, Guzman JP, Orlandi C, Hanauer SB. (2007)
A randomized, placebo-controlled, phase II study of tetomilast in active ulcerative colitis. Gastroenterology, 132 (1): 76-86. [PMID:17241861] |